Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 377.50
-6.90 (-1.80%)
Oct 9, 2025, 1:35 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.71 trillion as of October 9, 2025. Its market cap has decreased by -54.67% in one year.
Market Cap
1.71T
Enterprise Value
1.79T
Revenue
311.94B
Ranking
n/a
PE Ratio
15.40
Stock Price
377.50
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.71T, an increase of 3,612.98%. That is a compound annual growth rate of 13.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 1,708.05B | -38.39% |
| Dec 30, 2024 | 2,772.28B | -10.93% |
| Dec 29, 2023 | 3,112.33B | 46.89% |
| Dec 30, 2022 | 2,118.80B | 26.50% |
| Dec 30, 2021 | 1,674.99B | 69.77% |
| Dec 30, 2020 | 986.61B | 8.50% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 130.43B |
| Coloplast | 129.47B |
| Demant | 49.12B |
| ALK-Abelló | 47.07B |
| H. Lundbeck | 43.97B |
| Zealand Pharma | 35.92B |
| Ambu A/S | 28.40B |
| Bavarian Nordic | 18.00B |